India’s healthcare sector stands on the cusp of significant changes. Prime Minister Narendra Modi’s recent announcement regarding “next-generation GST reforms” has garnered strong support from healthcare stakeholders, notably NATHEALTH. Indeed, these proposed reforms offer a timely opportunity to re-evaluate the existing tax framework for the healthcare industry. Therefore, the discussion around healthcare GST reform is gaining momentum, promising a more streamlined and equitable system.
NATHEALTH’s Vision for GST
NATHEALTH, a prominent lobby group for the healthcare industry, actively welcomes the government’s initiative. They propose standardizing GST slabs at 5% for healthcare services. Furthermore, they advocate for allowing providers to claim input credit wherever GST output payments are applicable. This measure would significantly ease the financial burden on healthcare providers, ultimately benefiting millions of Indians who depend on quality care.
Current GST Structure and Proposed Changes
Currently, medical devices face a 12% GST slab. Moreover, services such as contractual manpower incur an 18% GST. The upcoming revamp aims to eliminate the 12% and 28% slabs. Conversely, the government expects the 5% and 18% slabs to continue. NATHEALTH suggests that embedded taxes constitute an estimated 5.7% of total revenue for hospitals. Similarly, the impact is around 5.8% for diagnostic laboratories and testing centers. Consequently, a pragmatic GST structure would reduce these embedded taxes.
Empowering Providers and Patients through Input Credit
Allowing input tax credit (ITC) for healthcare businesses aligns with practices in other industries like textiles. The existing GST rules of 2017 define ITC as a system that helps businesses lower their tax liability. They achieve this by claiming credits on GST paid for business-related purchases. This reform could reinforce investor confidence, providing the sector stability. Hence, capacity expansion and innovation scaling become more feasible, making healthcare more affordable and accessible for all citizens.
Pharmaceutical Sector and Fiscal Implications of Healthcare GST Reform
Pharmaceuticals, including essential and life-saving drugs, currently fall under the 5% slab. This rate is likely to persist under the new framework. Vishal Manchanda, a pharma analyst at Systematix Group, believes the proposed revamp could modestly aid volumes. However, he projects it will remain margin neutral for companies. Significantly, consumers will likely receive these benefits, making drugs more affordable. An IDFC First Bank report suggests the rationalization might cause a revenue loss of ₹1.8 trillion, equal to 0.5% of GDP. States would bear a larger share of this burden, receiving over 40% of CGST inflows in addition to their SGST collections.
Frequently Asked Questions
Q1: What are NATHEALTH’s key recommendations for healthcare GST reform?
NATHEALTH advocates for standardizing GST slabs at 5% for healthcare services and allowing providers to claim input tax credit wherever GST output payments apply.
Q2: How does the proposed GST revamp impact medical devices?
Under the current regime, medical devices are subject to a 12% GST. The proposed revamp aims to discontinue the 12% slab, which could lead to changes in taxation for medical devices, potentially reducing their cost if they move to a lower slab or become eligible for input credit.
Q3: Will the GST changes affect the cost of medicines?
Pharmaceuticals, including essential and life-saving drugs, are currently in the 5% slab, which is expected to continue. While the proposed changes are projected to be margin neutral for companies, the benefits may be passed on to consumers, potentially making drugs more affordable.
References
- NATHEALTH backs GST rate revamp; Seeks input credit for healthcare industry – ETHealthworld
- GST on Healthcare Services – Everything You Need to Know – Bajaj Finance
- GST in Healthcare Sector Impact | CaptainBiz
- Impact of GST on Healthcare and Pharma Sector – ClearTax
- GST on Healthcare Services: What Every Patient Needs to Know – Suvit
- FAQs ON GOODS AND SERVICES TAX (GST)
- NATHEALTH urges govt to increase public health expenditure to over 2.5% of GDP – Zee Business
- Budget 2023: NATHEALTH seeks rationalisation of GST for healthcare sector
- NATHEALTH recommends strategies to boost healthcare industry in upcoming budget
- NATHEALTH calls for boost in healthcare spending, reforming GST in Budget 2024-25
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.